These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7862640)

  • 21. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
    Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
    Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE).
    Marengo SR; Sikes RA; Anezinis P; Chang SM; Chung LW
    Mol Carcinog; 1997 Jul; 19(3):165-75. PubMed ID: 9254883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
    Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
    J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of focal contact formation in cells transformed by p185neu.
    Lo SS; Lo SH; Wang SC; Hung MC
    Mol Carcinog; 1999 Jun; 25(2):150-4. PubMed ID: 10365917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a neu/c-erbB-2 protein-specific activating factor.
    Dobashi K; Davis JG; Mikami Y; Freeman JK; Hamuro J; Greene MI
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8582-6. PubMed ID: 1717981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein.
    Dougall WC; Greene MI
    Cell Biophys; 1994; 24-25():209-18. PubMed ID: 7736525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.
    Juang SH; Carvajal ME; Whitney M; Liu Y; Carraway CA
    Oncogene; 1996 Mar; 12(5):1033-42. PubMed ID: 8649794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC
    Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p185neu expression in human lung adenocarcinomas predicts shortened survival.
    Kern JA; Schwartz DA; Nordberg JE; Weiner DB; Greene MI; Torney L; Robinson RA
    Cancer Res; 1990 Aug; 50(16):5184-7. PubMed ID: 1974168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
    Weiner DB; Nordberg J; Robinson R; Nowell PC; Gazdar A; Greene MI; Williams WV; Cohen JA; Kern JA
    Cancer Res; 1990 Jan; 50(2):421-5. PubMed ID: 1967224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
    Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA
    Int J Immunopathol Pharmacol; 2005; 18(2):351-63. PubMed ID: 15888257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.
    Tsai CM; Chang KT; Wu LH; Chen JY; Gazdar AF; Mitsudomi T; Chen MH; Perng RP
    Cancer Res; 1996 Jan; 56(1):206-9. PubMed ID: 8548764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p185neu is expressed in yolk sac during rat postimplantation development.
    Knezevic V; Spaventi R; Poljak L; Slade N; Svajger A; Pavelic K
    J Anat; 1994 Aug; 185 ( Pt 1)(Pt 1):181-7. PubMed ID: 7559112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells.
    Zhang HT; Zhang X; Zhao HZ; Kajino Y; Weber BL; Davis JG; Wang Q; O'Rourke DM; Zhang HB; Kajino K; Greene MI
    Oncogene; 1997 Jun; 14(24):2863-9. PubMed ID: 9205094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M; Osborne M; Telang NT
    Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.